Chemokine-like factor-like MARVEL transmembrane domain containing 6: Bioinformatics and experiments in vitro analyze in glioblastoma multiforme.
Chemokine-like factor-like MARVEL transmembrane domain containing 6: Bioinformatics and experiments in vitro analyze in glioblastoma multiforme.
复制标题
DOI:
10.3389/fnmol.2022.1026927
复制
发表时间:
2022
影响因子:
4.8
通讯作者:
Qu, Yan
中科院分区:
文献类型:
--
作者:
Meng, Haining;Li, Shaohua;Li, Qingshu;Wang, Yuqin;Wang, Guoan;Qu, Yan
Chemokine-like factor (CKLF)-like MARVEL transmembrane domain containing 6 (CMTM6) is a protein localized to the cell membrane and is known for its ability to co-localize with PD-L1 on the plasma membrane, prevent PD-L1 degradation, and maintain PD-L1 expression on the cell membrane. CMTM6 is highly expressed and plays an important role in various tumors such as oral squamous cell carcinoma (OSCC) and colorectal cancer (CRC), however, its role in Glioblastoma multiforme (GBM) is unclear. In this paper, to investigate the role of CMTM6 in GBM, we analyzed the expression of CMTM6 in GBM, the interaction with CMTM6 and the associated genes by bioinformatics. Importantly, we analyzed the expression of CMTM6 in GBM in relation to tumor-infiltrating lymphocytes (TILs), immunoinhibitors, immunostimulators, chemokines and chemokine receptors. We further analyzed the function of CMTM6 and performed in vitro experiments to verify it. Finally, the sensitivity of CMTM6 to drugs was also analyzed and the relationship between CMTM6 and the anticancer drug Piperlonguminine (PL) was verified in vitro. The results showed that CMTM6 was highly expressed in GBM and correlated with multiple genes. Furthermore, CMTM6 is closely related to the immune microenvironment and inflammatory response in GBM. Bioinformatic analysis of CMTM6 correlated with the function of GBM, and our experiments demonstrated that CMTM6 significantly promoted the migration of GBM cells and epithelial-mesenchymal transition (EMT), but had no significant effect on other functions. Interestingly, we found that in GBM, PL promotes the expression of CMTM6. In this paper, we have performed a detailed analysis and validation of the role of CMTM6 in GBM using bioinformatics analysis and in vitro experiments to demonstrate that CMTM6 may be a potential target for glioma therapy.
登录
查看更多内容
影响因子:
7.2
作者:
Wang H;Fan Y;Chen W;Lv Z;Wu S;Xuan Y;Wang C;Lu Y;Guo T;Shen D;Zhang F;Huang Q;Gao Y;Li H;Ma X;Wang B;Huang Y;Zhang X
通讯作者:
Zhang X
影响因子:
7.2
作者:
Martinez-Morilla S;Zugazagoitia J;Wong PF;Kluger HM;Rimm DL
通讯作者:
Rimm DL
DOI:
10.1007/s00262-020-02691-9
发表时间:
2021-03
期刊:
Cancer immunology, immunotherapy : CII
影响因子:
--
作者:
Liu LL;Zhang SW;Chao X;Wang CH;Yang X;Zhang XK;Wen YL;Yun JP;Luo RZ
通讯作者:
Luo RZ
影响因子:
5.6
作者:
Wang, Hui;Gao, Jinping;Wang, Haiyong
通讯作者:
Wang, Haiyong
DOI:
10.1016/j.bbrc.2013.06.042
发表时间:
2013-07-19
影响因子:
3.1
作者:
Liu, Ju Mei;Pan, Feng;Chen, Xiao Qian
通讯作者:
Chen, Xiao Qian